Article Information
vol. 42 no. 6 1446-1448
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 31, 2013
- Accepted June 3, 2013
- Published online November 30, 2013.
Copyright & Usage
©ERS 2013
Author Information
- David J. Lederer1,2⇑
- 1Dept of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY
- 2Dept of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA
- D.J. Lederer, Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University, 622 W 168th Street, PH8-101, New York, NY, USA. E-mail: DavidLederer{at}columbia.edu
Article usage
Altmetrics
Vol 42 Issue 6
Table of Contents
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward
Jump To
- Article
- Assumption 1: we should only study IPF patients with mild-to-moderate disease
- Assumption 2: non-pharmacological management does not matter
- Assumption 3: FVC will capture the clinical efficacy of a novel therapy for IPF
- Assumption 4: the study of human lung diseases does not require humans
- Footnotes
- References
- Figures & Data
- Info & Metrics